Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting
- Written by PR Newswire Asia - Daily Bulletin Au RSS
![]() |
- The data provides further validation of the intended Phase 2 study design
MELBOURNE, Australia and SAN FRANCISCO, April 7, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...